Sold as Indium In 111 Chloride, Indiclor. Every FDA application for this active ingredient.
As of Nov 16, 2026, FDA lists 2 applications for Indium In-111 Chloride (sold as Indium In 111 Chloride, Indiclor), first approved Dec 29, 1992, with 1 new use approved and 0 published complete response letters.
| Dec 29, 1992 | IndiclorNDA 19862 · New molecular entity | Ge Healthcare | 5 | Discontinued |
| Sep 27, 1994 | Indium In 111 ChlorideNDA 19841 · New molecular entity | Curium | 4 | Discontinued |
Applications, approvals and products come from FDA's Drugs@FDA data files, refreshed weekly, grouped by active ingredient as FDA spells it. Complete response letters are FDA's published letters. Medicare spending is CMS's Part D and Part B dashboard, matched to this ingredient by generic name; shortages are FDA's shortage list, matched by application number; clinical trials are ClinicalTrials.gov studies naming the ingredient as an intervention, refreshed daily; safety programs are FDA's REMS list, matched by application number or, for shared programs, by ingredient. Drugs@FDA